Yüklüyor......
Phase I Trial of Continuous Infusion Anti-Mesothelin Recombinant Immunotoxin SS1P
PURPOSE: To conduct a Phase I trial of recombinant immunotoxin SS1P given by continuous infusion in chemoresistant solid tumors expressing mesothelin. EXPERIMENTAL DESIGN: Eligible patients had mesothelioma, ovarian, or pancreatic cancer which was recurrent or unresectable despite standard therapy,...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2009
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2754261/ https://ncbi.nlm.nih.gov/pubmed/19671873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-0062 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|